Sowell Financial Services’s Evogene EVGN Stock Holding History

Sowell Financial Services’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35	Closed	-$1K	–	1188
2021 Q1	$1K	Buy	+35	New	+$2.17K	﹤0.01%	2929

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PDT Partners New York $1.9B AUM 71.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Sowell Financial Services's EVGN Position: Q2 2021 in Review

Sowell Financial Services sold out of Evogene (EVGN) in Q2 2021, closing a stake of 35 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in EVGN in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 42 funds tracked by Wall St. Rank hold EVGN as of Q2 2021.

Sowell Financial Services reported no remaining Evogene position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 35 Evogene shares in Q2 2021, an estimated $1K.
Sowell Financial Services first reported a position in Evogene in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's Evogene position peaked at $1K in Q1 2021.
42 funds tracked by Wall St. Rank held Evogene as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.